1. Hambrock, H. (2004). O, Kaufmann B, Müller S, Hanisch F, G, Nose K, Paulsson M, Maurer P, Hartmann U. Structural characterization of TSC-36/Flik: analysis of two charge isoforms. J Biol Chem, 279, 11727-11735.
2. Li, X., Li, L., Chang, Y., Ning, W., & Liu, X. (2019). Structural and functional study of FK domain of Fstl1. Protein Science, 28(10), 1819-1829.‌
3. Johnston, I. M., Spence, H. J., Winnie, J. N., McGarry, L., Vass, J. K., Meagher, L., & Ozanne, B. W. (2000). Regulation of a multigenic invasion programme by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion. Oncogene, 19(47), 5348-5358.‌ https://doi.org/10.1038/sj.onc.1203927.
4. Kawabata, D., Tanaka, M., Fujii, T., Umehara, H., Fujita, Y., Yoshifuji, H., ... & Ozaki, S. (2004). Ameliorative effects of follistatin‐related protein/TSC‐36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 50(2), 660-668.‌
5. Niekraszewicz, B., & Niekraszewicz, A. (2009). The structure of alginate, chitin and chitosan fibres. In Handbook of textile fibre structure. Woodhead Publishing, 230, 266-304.
6. Miyabe, M., Ohashi, K., Shibata, R., Uemura, Y., Ogura, Y., Yuasa, D., ... & Ouchi, N. (2014). Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury. Cardiovascular research, 103(1), 111-120.‌
7. Jafari, S. S., Jafarian, V., Khalifeh, K., Ghanavatian, P., & Shirdel, S. A. (2016). The effect of charge alteration and flexibility on the function and structural stability of sweet-tasting brazzein. RSC advances, 6(64), 59834-59841.‌
8. Ni, X., Cao, X., Wu, Y., & Wu, J. (2018). FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer. Oncology Reports, 39(1), 13-20.‌
9. Mattiotti, A., Prakash, S., Barnett, P., & van den Hoff, M. J. (2018). Follistatin-like 1 in development and human diseases. Cellular and Molecular Life Sciences, 75(13), 2339-2354.‌
10. Chaly, Y., Blair, H. C., Smith, S. M., Bushnell, D. S., Marinov, A. D., Campfield, B. T., & Hirsch, R. (2015). Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells. Annals of the rheumatic diseases, 74(7), 1467-1473.
11. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. Journal of computational chemistry, 25(13), 1605-1612.‌
12. Ouchi, N., Oshima, Y., Ohashi, K., Higuchi, A., Ikegami, C., Izumiya, Y., & Walsh, K. (2008). Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. Journal of Biological Chemistry, 283(47), 32802-32811.
13. Ogura, Y., Ouchi, N., Ohashi, K., Shibata, R., Kataoka, Y., Kambara, T., ... & Murohara, T. (2012). Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models. Circulation, 126(14), 1728-1738.‌
14. Sumitomo, K., Kurisaki, A., Yamakawa, N., Tsuchida, K., Shimizu, E., Sone, S., & Sugino, H. (2000). Expression of a TGF-β1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines. Cancer letters, 155(1), 37-46.‌
15. Trombetta-eSilva, J., & Bradshaw, A. D. (2012). Suppl 1: the function of SPARC as a mediator of fibrosis. The open rheumatology journal, 6, 146.
16. Sundaram, G. M., Common, J. E., Gopal, F. E., Srikanta, S., Lakshman, K., Lunny, D. P.,& Sampath, P. (2013). ‘See-saw’expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature, 495(7439), 103-106.‌
17. Sylva, M., Moorman, A. F. M., & Van den Hoff, M. J. B. (2013). Follistatin‐like 1 in vertebrate development. Birth Defects Research Part C: Embryo Today: Reviews, 99(1), 61-69.
18. Shi, D. L., Shi, G. R., Xie, J., Du, X. Z., & Yang, H. (2016). MicroRNA-27a inhibits cell migration and invasion of fibroblast-like synoviocytes by targeting follistatin-like protein 1 in rheumatoid arthritis. Molecules and cells, 39(8), 611.
19. Xi, Y., Gong, D. W., & Tian, Z. (2016). FSTL1 as a potential mediator of exercise-induced cardioprotection in post-myocardial infarction rats. Scientific reports, 6(1), 1-11.
20. Xu, C., Jiang, T., Ni, S., Chen, C., Li, C., Zhuang, C., & Wang, Y. (2020). FSTL1 promotes nitric oxide-induced chondrocyte apoptosis via activating the SAPK/JNK/caspase3 signaling pathway. Gene, 732, 144339.‌
21. Chaly, Y., Marinov, A. D., Oxburgh, L., Bushnell, D. S., & Hirsch, R. (2012). FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expression. Arthritis & Rheumatism, 64(4), 1082-1088.
22. Wu, J., Dong, Y., Teng, X., Cheng, M., Shen, Z., & Chen, W. (2015). Follistatin-like 1 attenuates differentiation and survival of erythroid cells through Smad2/3 signaling. Biochemical and Biophysical Research Communications, 466(4), 711-716.‌
23. Farzannia, A., Roghanian, R., Zarkesh-Esfahani, S. H., Nazari, M., & Emamzadeh, R. (2015). FcUni-RLuc: an engineered Renilla luciferase with Fc binding ability and light emission activity. Analyst, 140(5), 1438-1441.
24. Miyamae, T., Marinov, A. D., Sowders, D., Wilson, D. C., Devlin, J., Boudreau, R., ... & Hirsch, R. (2006). Follistatin-like protein-1 is a novel proinflammatory molecule. The Journal of Immunology, 177(7), 4758-4762.‌
25. Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo Jr, R., KMM, O. A., Simmerling, C., Wang, B., and Woods, RJ (2005). The Amber biomolecular simulation programs. J. Comput. Chem, 26, 1668-1688.‌
26. Greenfield, N. J., & Pietruszko, R. (1977). Two aldehyde dehydrogenases from human liver. Isolation via affinity chromatography and characterization of the isozymes. Biochimica Biophysica Acta (BBA)-Enzymology, 483(1), 35-45.‌
27. Chan, Q. K., Ngan, H. Y., Ip, P. P., Liu, V. W., Xue, W. C., & Cheung, A. N. (2009). Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis—a differential expression and functional analysis. Carcinogenesis, 30(1), 114-121.
28. Emamzadeh, R., Nazari, M., & Najafzadeh, S. (2014). Adherent state apoptosis assay (ASA): a fast and reliable method to detect apoptosis in adherent cells. Analytical Methods, 6(12), 4199-4204.‌
29. Fang, Y., Zhang, S., Li, X., Jiang, F., Ye, Q., & Ning, W. (2017). Follistatin like-1 aggravates silica-induced mouse lung injury. Scientific Reports, 7(1), 1-12.‌
30. Ding, F., & Peng, W. (2019). Probing the local conformational flexibility in receptor recognition: mechanistic insight from an atomic-scale investigation. RSC advances, 9(25), 13968-13980.‌
31. Chidambaram, S., Ali, D., Alarifi, S., Gurusamy, R., Radhakrishnan, S., & Akbar, I. (2021). Tyrosinase-mediated synthesis of larvicidal active 1, 5-diphenyl pent-4-en-1-one derivatives against Culex quinquefasciatus and investigation of their ichthyotoxicity. Scientific reports, 11(1), 1-18.‌
32. Alteköester, A. K., & Harvey, R. P. (2015). Bioengineered FSTL1 patches restore cardiac function following myocardial infarction. Trends in Molecular Medicine, 21(12), 731-733.
33. Mukherjee, J., & Gupta, M. N. (2015). Increasing importance of protein flexibility in designing biocatalytic processes. Biotechnology Reports, 6, 119-123. ‌
34. Nazari, M., Zarnani, A. H., Ghods, R., Emamzadeh, R., Najafzadeh, S., Minai-Tehrani, A., ... & Nejadmoghaddam, M. R. (2017). Optimized protocol for soluble prokaryotic expression, purification and structural analysis of human placenta specific-1 (PLAC1). Protein Expression and Purification, 133, 139-151.‌
35. Jafari, S.S., Emamzadeh, R., Nazari, M., S. Jafari., M.R., & Ganjalikhany. (2023). Investigation of 36-32 disulfide bond in structural changes and flexibility of FK domain of FSTL1 protein: An in silico study. Cellular and Molecular Research (Iranian Journal of Biology).‌